Menu

Linked-Reads: Find the Answer to What's Been Missing

Learn more about assembling the genome easily with this poster from The Scientist and 10X Genomics!

Sep 30, 2017
The Scientist Creative Services Team

Organisms and biology are immensely complex, and to truly understand disease mechanisms, heritability, potential diagnoses, and development of therapies, we need access to more genomic information. Linked-Reads constructs long-range information from short-reads to provide access to hidden and inaccessible information. With Linked-Reads, researchers now have the power to resolve ambiguous single nucleotide variants, provide phasing and haplotype information, identify structural variants, and assemble genomes without the need for a reference sequence. 

Download this poster from The Scientist, sponsored by 10X Genomics to learn about linked reads, structural variants, and resolving haplotypes!

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.